151 related articles for article (PubMed ID: 12666535)
21. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
Yakovlev SV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
[No Abstract] [Full Text] [Related]
22. [Efficacy trial in general practice substantiated. New antibiotic with strong effectiveness and tolerance].
MMW Fortschr Med; 2002 Oct; 144(42):60-1. PubMed ID: 12534000
[No Abstract] [Full Text] [Related]
23. [Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].
Gaillat J
Presse Med; 2001 Oct; 30(31 Pt 2):17-22. PubMed ID: 11721486
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetically enhanced amoxicillin/clavulanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains.
Anon JB; Ferguson B; Twynholm M; Wynne B; Berkowitz E; Poole MD
Ear Nose Throat J; 2006 Aug; 85(8):500, 502, 504 passim. PubMed ID: 16999056
[TBL] [Abstract][Full Text] [Related]
25. Telithromycin (Ketek) for respiratory infections.
Med Lett Drugs Ther; 2004 Aug; 46(1189):66-8. PubMed ID: 15314586
[No Abstract] [Full Text] [Related]
26. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections.
Nord CE; Farrell DJ; Leclercq R
Microb Drug Resist; 2004; 10(3):255-63. PubMed ID: 15383171
[TBL] [Abstract][Full Text] [Related]
27. [Importance in respiratory tract infections. Ketolides: clinical aspects].
Lorenz J; Steiert P
Pharm Unserer Zeit; 2004; 33(1):42-6. PubMed ID: 14968712
[No Abstract] [Full Text] [Related]
28. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
Reinert RR
J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
[TBL] [Abstract][Full Text] [Related]
29. Comparison of adherence between twice- and thrice-daily regimens of oral amoxicillin/clavulanic acid.
Llor C; Bayona C; Hernández S; Moragas A; Miravitlles M
Respirology; 2012 May; 17(4):687-92. PubMed ID: 22390206
[TBL] [Abstract][Full Text] [Related]
30. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
[TBL] [Abstract][Full Text] [Related]
31. [A case of temporal arteritis presenting with sensorineural hearing loss].
Amoroso C; Vindigni MR; Aimoni C
Recenti Prog Med; 2001 Dec; 92(12):751-3. PubMed ID: 11822096
[TBL] [Abstract][Full Text] [Related]
32. Dosing of amoxicillin/clavulanate for treatment of lower respiratory tract infection.
Natsch S; van der Meer JW
Clin Infect Dis; 1998 Feb; 26(2):529-30. PubMed ID: 9502501
[No Abstract] [Full Text] [Related]
33. Amoxycillin/clavulanic acid prophylaxis in elective colorectal surgery.
Byrne DJ
J Hosp Infect; 1998 Apr; 38(4):319-20. PubMed ID: 9602980
[No Abstract] [Full Text] [Related]
34. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A
J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517
[TBL] [Abstract][Full Text] [Related]
35. Impact of unlabeled French antibiotic guidelines on antibiotic prescriptions for acute respiratory tract infections in 7 Pediatric Emergency Departments, 2009-2012.
Angoulvant F; Pereira M; Perreaux F; Soussan V; Pham LL; Trieu TV; Cojocaru B; Guedj R; Cohen R; Alberti C; Gajdos V
Pediatr Infect Dis J; 2014 Mar; 33(3):330-3. PubMed ID: 24168976
[TBL] [Abstract][Full Text] [Related]
36. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease.
Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM
Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816
[TBL] [Abstract][Full Text] [Related]
37. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
Ricart E; Soriano G; Novella MT; Ortiz J; Sàbat M; Kolle L; Sola-Vera J; Miñana J; Dedéu JM; Gómez C; Barrio JL; Guarner C
J Hepatol; 2000 Apr; 32(4):596-602. PubMed ID: 10782908
[TBL] [Abstract][Full Text] [Related]
38. [Lemierre's syndrome: a case report].
Lemiale V; Saidi F; Jais X; Vincent B; Parrot A; Mayaud C
Rev Pneumol Clin; 2001 Feb; 57(1 Pt 1):38-40. PubMed ID: 11373604
[TBL] [Abstract][Full Text] [Related]
39. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
40. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
